PIAS3_HUMAN - dbPTM
PIAS3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PIAS3_HUMAN
UniProt AC Q9Y6X2
Protein Name E3 SUMO-protein ligase PIAS3
Gene Name PIAS3
Organism Homo sapiens (Human).
Sequence Length 628
Subcellular Localization Cytoplasm . Nucleus . Nucleus speckle . Colocalizes with MITF in the nucleus. Colocalizes with GFI1 in nuclear dots. Colocalizes with SUMO1 in nuclear granules.
Protein Description Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway and the steroid hormone signaling pathway. Involved in regulating STAT3 signaling via inhibiting STAT3 DNA-binding and suppressing cell growth. Enhances the sumoylation of MTA1 and may participate in its paralog-selective sumoylation. [PubMed: 21965678]
Protein Sequence MAELGELKHMVMSFRVSELQVLLGFAGRNKSGRKHELLAKALHLLKSSCAPSVQMKIKELYRRRFPRKTLGPSDLSLLSLPPGTSPVGSPGPLAPIPPTLLAPGTLLGPKREVDMHPPLPQPVHPDVTMKPLPFYEVYGELIRPTTLASTSSQRFEEAHFTFALTPQQVQQILTSREVLPGAKCDYTIQVQLRFCLCETSCPQEDYFPPNLFVKVNGKLCPLPGYLPPTKNGAEPKRPSRPINITPLARLSATVPNTIVVNWSSEFGRNYSLSVYLVRQLTAGTLLQKLRAKGIRNPDHSRALIKEKLTADPDSEVATTSLRVSLMCPLGKMRLTVPCRALTCAHLQSFDAALYLQMNEKKPTWTCPVCDKKAPYESLIIDGLFMEILSSCSDCDEIQFMEDGSWCPMKPKKEASEVCPPPGYGLDGLQYSPVQGGDPSENKKKVEVIDLTIESSSDEEDLPPTKKHCSVTSAAIPALPGSKGVLTSGHQPSSVLRSPAMGTLGGDFLSSLPLHEYPPAFPLGADIQGLDLFSFLQTESQHYGPSVITSLDEQDALGHFFQYRGTPSHFLGPLAPTLGSSHCSATPAPPPGRVSSIVAPGGALREGHGGPLPSGPSLTGCRSDIISLD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAELGELKH
------CCCHHHHHH
22.26-
8UbiquitinationMAELGELKHMVMSFR
CCCHHHHHHHHHHCC
25.92-
13PhosphorylationELKHMVMSFRVSELQ
HHHHHHHHCCHHHHH
9.8624719451
34UbiquitinationGRNKSGRKHELLAKA
CCCCCCCHHHHHHHH
44.98-
46SumoylationAKALHLLKSSCAPSV
HHHHHHHHHCCCCHH
46.84-
46SumoylationAKALHLLKSSCAPSV
HHHHHHHHHCCCCHH
46.8428112733
56SumoylationCAPSVQMKIKELYRR
CCCHHHHHHHHHHHH
33.27-
56UbiquitinationCAPSVQMKIKELYRR
CCCHHHHHHHHHHHH
33.27-
56SumoylationCAPSVQMKIKELYRR
CCCHHHHHHHHHHHH
33.2728112733
58SumoylationPSVQMKIKELYRRRF
CHHHHHHHHHHHHHC
35.83-
58SumoylationPSVQMKIKELYRRRF
CHHHHHHHHHHHHHC
35.83-
58UbiquitinationPSVQMKIKELYRRRF
CHHHHHHHHHHHHHC
35.83-
84PhosphorylationLLSLPPGTSPVGSPG
HHCCCCCCCCCCCCC
35.3128348404
85PhosphorylationLSLPPGTSPVGSPGP
HCCCCCCCCCCCCCC
24.4128348404
89PhosphorylationPGTSPVGSPGPLAPI
CCCCCCCCCCCCCCC
27.2428348404
165PhosphorylationAHFTFALTPQQVQQI
CCEEEECCHHHHHHH
18.6722210691
174PhosphorylationQQVQQILTSREVLPG
HHHHHHHHCCCCCCC
27.6322210691
183AcetylationREVLPGAKCDYTIQV
CCCCCCCCCCEEEEE
33.2926051181
183UbiquitinationREVLPGAKCDYTIQV
CCCCCCCCCCEEEEE
33.29-
230SumoylationPGYLPPTKNGAEPKR
CCCCCCCCCCCCCCC
60.19-
230SumoylationPGYLPPTKNGAEPKR
CCCCCCCCCCCCCCC
60.1928112733
236UbiquitinationTKNGAEPKRPSRPIN
CCCCCCCCCCCCCCC
69.33-
288SumoylationTAGTLLQKLRAKGIR
HHHHHHHHHHHCCCC
39.65-
288UbiquitinationTAGTLLQKLRAKGIR
HHHHHHHHHHHCCCC
39.65-
288SumoylationTAGTLLQKLRAKGIR
HHHHHHHHHHHCCCC
39.65-
295Asymmetric dimethylarginineKLRAKGIRNPDHSRA
HHHHCCCCCCHHHHH
58.24-
300PhosphorylationGIRNPDHSRALIKEK
CCCCCHHHHHHHHHH
26.9922964224
305UbiquitinationDHSRALIKEKLTADP
HHHHHHHHHHHCCCC
50.04-
307UbiquitinationSRALIKEKLTADPDS
HHHHHHHHHCCCCCC
46.2521906983
307SumoylationSRALIKEKLTADPDS
HHHHHHHHHCCCCCC
46.25-
307SumoylationSRALIKEKLTADPDS
HHHHHHHHHCCCCCC
46.2528112733
331SumoylationSLMCPLGKMRLTVPC
EEECCCCCCEEECCC
28.64-
331UbiquitinationSLMCPLGKMRLTVPC
EEECCCCCCEEECCC
28.64-
331SumoylationSLMCPLGKMRLTVPC
EEECCCCCCEEECCC
28.64-
361SumoylationYLQMNEKKPTWTCPV
HHHCCCCCCCEECCC
41.31-
361SumoylationYLQMNEKKPTWTCPV
HHHCCCCCCCEECCC
41.31-
372UbiquitinationTCPVCDKKAPYESLI
ECCCCCCCCCHHHEE
41.15-
415PhosphorylationMKPKKEASEVCPPPG
CCCCCCHHCCCCCCC
31.4923312004
423PhosphorylationEVCPPPGYGLDGLQY
CCCCCCCCCCCCCCC
21.9329978859
430PhosphorylationYGLDGLQYSPVQGGD
CCCCCCCCCCCCCCC
21.7125159151
431PhosphorylationGLDGLQYSPVQGGDP
CCCCCCCCCCCCCCC
12.9725849741
439PhosphorylationPVQGGDPSENKKKVE
CCCCCCCCCCCCEEE
59.5529978859
442UbiquitinationGGDPSENKKKVEVID
CCCCCCCCCEEEEEE
50.33-
443UbiquitinationGDPSENKKKVEVIDL
CCCCCCCCEEEEEEE
73.89-
451PhosphorylationKVEVIDLTIESSSDE
EEEEEEEEEECCCCC
20.9628102081
454PhosphorylationVIDLTIESSSDEEDL
EEEEEEECCCCCCCC
31.1528102081
455PhosphorylationIDLTIESSSDEEDLP
EEEEEECCCCCCCCC
29.0828102081
456PhosphorylationDLTIESSSDEEDLPP
EEEEECCCCCCCCCC
59.3228102081
464PhosphorylationDEEDLPPTKKHCSVT
CCCCCCCCCCCCCCC
51.2728102081
466SumoylationEDLPPTKKHCSVTSA
CCCCCCCCCCCCCCC
52.9328112733
466UbiquitinationEDLPPTKKHCSVTSA
CCCCCCCCCCCCCCC
52.93-
469PhosphorylationPPTKKHCSVTSAAIP
CCCCCCCCCCCCCCC
28.3123532336
471PhosphorylationTKKHCSVTSAAIPAL
CCCCCCCCCCCCCCC
9.0623532336
472PhosphorylationKKHCSVTSAAIPALP
CCCCCCCCCCCCCCC
17.3423532336
482UbiquitinationIPALPGSKGVLTSGH
CCCCCCCCCCCCCCC
59.98-
482SumoylationIPALPGSKGVLTSGH
CCCCCCCCCCCCCCC
59.9828112733
492PhosphorylationLTSGHQPSSVLRSPA
CCCCCCCCHHHCCCC
26.89-
497PhosphorylationQPSSVLRSPAMGTLG
CCCHHHCCCCCCCCC
16.9223532336
595PhosphorylationPPPGRVSSIVAPGGA
CCCCCEEEEEECCCC
20.4428857561

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseTRIM32Q13049
PMID:17987106

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PIAS3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PIAS3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TF65_HUMANRELAphysical
15140884
SMAD2_HUMANSMAD2physical
14691252
SMAD3_HUMANSMAD3physical
14691252
SMAD4_HUMANSMAD4physical
14691252
MITF_HUMANMITFphysical
11709556
HMGA2_HUMANHMGA2physical
11390395
GFI1_HUMANGFI1physical
11060035
TRI32_HUMANTRIM32physical
17987106
ZMIZ2_HUMANZMIZ2physical
20159969
CHSP1_HUMANCARHSP1physical
21900206
UBA1_HUMANUBA1physical
21900206
PRS4_HUMANPSMC1physical
21900206
CS060_HUMANC19orf60physical
21900206
RAC1_HUMANRAC1physical
20935639
STAT3_HUMANSTAT3physical
12804609
STAT3_MOUSEStat3physical
9388184
STAT3_HUMANSTAT3physical
9724754
ZPI_HUMANSERPINA10physical
21988832
STAT3_HUMANSTAT3physical
21988832
UBC9_HUMANUBE2Iphysical
21988832
TAB2_HUMANTAB2physical
24096733
HIC1_HUMANHIC1physical
23704280
TF65_HUMANRELAphysical
22649547
BC11A_HUMANBCL11Aphysical
18681895
SMUF2_HUMANSMURF2physical
26679521

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PIAS3_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP